Combination of selected opioids with muscarine antagonists for treating urinary incontinence
US8946290B2 · kind B2 · utility
1Cited by
7References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 23, 2011 |
| Grant date | Feb 3, 2015 |
| Priority date | — |
| Expiry date | Sep 23, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Active compound combinations of compounds of group A, particularly opioids such as (+)-(2R,3R)-1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol or a salt thereof with a physiologically tolerated acid, and compounds of group B, particularly anti-muscarine agents such as oxybutynin or a salt thereof with a physiologically tolerated acid suitable for treatment of an increased urge to urinate or urinary incontinence. Related pharmaceutical formulations and methods of treatment of an increased urge to urinate or urinary incontinence are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.